Qilian International Holding Group Ltd - Class A

Research Qilian International Holding Group Ltd - Class A (BGM) on Bullrun: market cap USD 75.25M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerBGM
• ExchangeNASDAQ
• CountryChina
• SectorHealthcare
• IndustryDrug Manufacturers-Specialty & Generic
• CurrencyUSD
• Market capUSD 75.25M
• Financial periodFY2024
• RevenueUSD 25.10M
• Revenue growth-46.0%
• Net income-USD 1.44M
• Free cash flowUSD 304.11K
• Gross margin16.4%

Valuation Snapshot

latest market cap is USD 75.25M.

About Qilian International Holding Group Ltd - Class A

BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline active pharmaceutical ingredients, which are used by pharmaceutical companies in the manufacturing of medications that use oxytetracycline as an active ingredient.

Frequently asked questions

What is Qilian International Holding Group Ltd - Class A's market cap?

Qilian International Holding Group Ltd - Class A's market capitalization is USD 75.25M.

What does Qilian International Holding Group Ltd - Class A do?

BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human;